isoproterenol has been researched along with Cancer of Pancreas in 9 studies
Isoproterenol: Isopropyl analog of EPINEPHRINE; beta-sympathomimetic that acts on the heart, bronchi, skeletal muscle, alimentary tract, etc. It is used mainly as bronchodilator and heart stimulant.
isoprenaline : A secondary amino compound that is noradrenaline in which one of the hydrogens attached to the nitrogen is replaced by an isopropyl group. A sympathomimetic acting almost exclusively on beta-adrenergic receptors, it is used (mainly as the hydrochloride salt) as a bronghodilator and heart stimulant for the management of a variety of cardiac disorders.
Excerpt | Relevance | Reference |
---|---|---|
"Neuropeptide Y (NPY) has been shown to inhibit insulin secretion from the islets of Langerhans." | 5.30 | Inhibition of glucose stimulated insulin secretion by neuropeptide Y is mediated via the Y1 receptor and inhibition of adenylyl cyclase in RIN 5AH rat insulinoma cells. ( Bloom, SR; Ghatei, MA; Hurley, JD; Karlsen, AE; Kulkarni, RN; Morgan, DG; Smith, DM; Wang, RM; Wang, ZL, 1998) |
" Amylin significantly reduced insulin secretion in rat insulinoma cell lines (Rin m5F cells) that were stimulated by either isoproterenol and forskolin, but it did not affect insulin secretion stimulated by isobutyl-methylxanthine (IBMX) or dibutyryl cyclic-adenosine monophosphate (db-cAMP)." | 3.68 | The effects of amylin on insulin secretion from Rin m5F cells and glycogen synthesis and lipogenesis in rat primary cultured hepatocytes. ( Abe, S; Ishizuka, J; Murakami, M; Satoh, Y; Shintani, S; Suzuki, K; Suzuki, S; Thompson, JC; Toyota, T, 1992) |
"The response of insulinoma tissue to glucose, alpha-ketoisocaproate, and the modifiers of insulin release, tolbutamide, isoproterenol, and acetylcholine, was studied." | 3.67 | Pharmacological modifications of insulin release in vitro from fuel-responsive transplantable insulinomas. ( Ferguson, DC; Hoenig, M; Matschinsky, FM, 1984) |
"Neuropeptide Y (NPY) has been shown to inhibit insulin secretion from the islets of Langerhans." | 1.30 | Inhibition of glucose stimulated insulin secretion by neuropeptide Y is mediated via the Y1 receptor and inhibition of adenylyl cyclase in RIN 5AH rat insulinoma cells. ( Bloom, SR; Ghatei, MA; Hurley, JD; Karlsen, AE; Kulkarni, RN; Morgan, DG; Smith, DM; Wang, RM; Wang, ZL, 1998) |
"One of the major manifestations of the carcinoid syndrome is secretory diarrhea thought to be due to overproduction of 5-hydroxytryptamine (5-HT)." | 1.28 | The effect of somatostatin on 5-hydroxytryptamine release from a carcinoid tumor. ( Haber, B; Ishizuka, J; Lawrence, JP; Thompson, JC; Townsend, CM, 1990) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (22.22) | 18.7374 |
1990's | 4 (44.44) | 18.2507 |
2000's | 2 (22.22) | 29.6817 |
2010's | 1 (11.11) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Eng, JW | 1 |
Reed, CB | 1 |
Kokolus, KM | 1 |
Pitoniak, R | 1 |
Utley, A | 1 |
Bucsek, MJ | 1 |
Ma, WW | 1 |
Repasky, EA | 1 |
Hylander, BL | 1 |
Askari, MD | 1 |
Tsao, MS | 1 |
Schuller, HM | 2 |
Al-Wadei, HA | 1 |
Majidi, M | 1 |
Hoenig, M | 1 |
Ferguson, DC | 1 |
Matschinsky, FM | 1 |
Vea, H | 1 |
Trovik, TS | 1 |
Sager, G | 1 |
Birkeland, K | 1 |
Revhaug, A | 1 |
Sundsfjord, J | 1 |
Jorde, R | 1 |
Morgan, DG | 1 |
Kulkarni, RN | 1 |
Hurley, JD | 1 |
Wang, ZL | 1 |
Wang, RM | 1 |
Ghatei, MA | 1 |
Karlsen, AE | 1 |
Bloom, SR | 1 |
Smith, DM | 1 |
Suzuki, S | 1 |
Murakami, M | 1 |
Abe, S | 1 |
Satoh, Y | 1 |
Shintani, S | 1 |
Ishizuka, J | 2 |
Suzuki, K | 1 |
Thompson, JC | 2 |
Toyota, T | 1 |
Lawrence, JP | 1 |
Haber, B | 1 |
Townsend, CM | 1 |
Pasmantier, R | 1 |
Danoff, A | 1 |
Fleischer, N | 1 |
Schubart, UK | 1 |
9 other studies available for isoproterenol and Cancer of Pancreas
Article | Year |
---|---|
Housing temperature-induced stress drives therapeutic resistance in murine tumour models through β2-adrenergic receptor activation.
Topics: Adrenergic beta-Agonists; Albumins; Animals; Antineoplastic Agents; Apoptosis; bcl-X Protein; Cell L | 2015 |
The tobacco-specific carcinogen, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone stimulates proliferation of immortalized human pancreatic duct epithelia through beta-adrenergic transactivation of EGF receptors.
Topics: Adrenergic beta-Agonists; Blotting, Western; Carcinogens; Carcinoma, Pancreatic Ductal; Cell Line, T | 2005 |
GABA B receptor is a novel drug target for pancreatic cancer.
Topics: Adrenergic beta-Agonists; Baclofen; Blotting, Western; Bromodeoxyuridine; Cell Line; Cell Line, Tumo | 2008 |
Pharmacological modifications of insulin release in vitro from fuel-responsive transplantable insulinomas.
Topics: Acetylcholine; Adenoma, Islet Cell; Animals; Blood Glucose; Glucagon; Glucose; Insulin; Insulinoma; | 1984 |
Return of beta-adrenergic sensitivity in a patient with insulinoma after removal of the tumour.
Topics: Adrenergic beta-Agonists; Adult; Blood Glucose; Epinephrine; Glucagon; Human Growth Hormone; Humans; | 1997 |
Inhibition of glucose stimulated insulin secretion by neuropeptide Y is mediated via the Y1 receptor and inhibition of adenylyl cyclase in RIN 5AH rat insulinoma cells.
Topics: Adenylyl Cyclase Inhibitors; Adenylyl Cyclases; Animals; Blotting, Northern; Cyclic AMP; Glucagon; G | 1998 |
The effects of amylin on insulin secretion from Rin m5F cells and glycogen synthesis and lipogenesis in rat primary cultured hepatocytes.
Topics: Acetates; Amyloid; Animals; Arginine; Blood Glucose; Cell Line; Cells, Cultured; Colforsin; Cyclic A | 1992 |
The effect of somatostatin on 5-hydroxytryptamine release from a carcinoid tumor.
Topics: Acetylcholine; Carcinoid Tumor; Humans; Isoproterenol; Octreotide; Pancreatic Neoplasms; Pentagastri | 1990 |
P19, a hormonally regulated phosphoprotein of peptide hormone-producing cells: secretagogue-induced phosphorylation in AtT-20 mouse pituitary tumor cells and in rat and hamster insulinoma cells.
Topics: 1-Methyl-3-isobutylxanthine; 8-Bromo Cyclic Adenosine Monophosphate; Adenoma, Islet Cell; Adrenocort | 1986 |